semaglutide usp for Weight Loss Semaglutide for Weight Loss

According to FDA prescribing information, gastrointestinal adverse events are among the most commonly reported side effects, with constipation affecting a significant proportion of patients, particularly during dose escalation phases

Discontinuing the medications has been shown to lead to rapid worsening of blood sugar and weight regain, even when accompanied by physical activity and calorie restriction

Kidney disease: Semaglutide is not renally cleared

Mattes K, Vellenga E, Schepers H

Reena Patel, a pharmacist and healthcare strategy consultant, advocates for a trauma-informed approach when managing people who have obesity

Table of Contents I